CDEK
← All drugs Report issue

vb6-845

Recombinant proteinexperimental

Clinical trial activity

1 trials · 1 clinical orgs · 0 marketing orgs

Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0

Earliest trial started May 1, 2007 (NCT00481936)

Timeline

2000s

  1. Jan 1, 2007

    Earliest Phase 1 Sponsor(trial)

Indications

Studied for

Mechanism of action

Chemistry & pharmacology

Chirality
Single Stereoisomer
Inorganic
No
Polymer
No
Multi-specific
No
Payload
deBouganin

Oral

No

Parenteral

No

Topical

No

Sources

Also known as

  • citatuzumab bogatox
  • vb6-485
  • vb6-845
  • vb6-845

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT00481936Phase 1May 1, 2007Viventia Biotech Inc.
Showing 1 of 1 trials
Page 1 / 1

Organizations

Research & Development (1)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Viventia Biotech Inc.For profit1112007
1 organizations
Page 1 / 1